Agomelatine SPC
June 16, 2009 at 10:33 am | In Prescribing Extra - Drugs |
Print
| No Comments
The Summary of Product Characteristics for agomelatine (Valdoxan®) is now available via the electronic Medicines Compendium (eMC).
As previously discussed, agomelatine is a new class of antidepressant. The SPC gives more details for this drug including known side effects, precautions and interactions.
Action: Clinicians who are considering using this new drug would be wise to review the SPC before starting a treatment.
Bookmark in del.icio.us